These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37986027)

  • 1. Remnant cholesterol and severity of nonalcoholic fatty liver disease.
    Huang H; Wang J; Wu L; Ruan J; Hou L; Shen C; Xu C
    Diabetol Metab Syndr; 2023 Nov; 15(1):238. PubMed ID: 37986027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
    Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease.
    Huang H; Xie J; Zeng Y; Liu Z; Miao M; Xu L; Xu C
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2907-2915. PubMed ID: 37186667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
    Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
    BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.
    Tutunchi H; Naeini F; Ebrahimi-Mameghani M; Mobasseri M; Naghshi S; Ostadrahimi A
    Int J Clin Pract; 2021 Jun; 75(6):e14131. PubMed ID: 33683797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis.
    Lu S; Xie Q; Kuang M; Hu C; Li X; Yang H; Sheng G; Xie G; Zou Y
    J Transl Med; 2023 Mar; 21(1):192. PubMed ID: 36915168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males.
    Peng K; Mo Z; Tian G
    Am J Med Sci; 2017 Mar; 353(3):236-241. PubMed ID: 28262209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
    Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
    World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol.
    Wu KT; Kuo PL; Su SB; Chen YY; Yeh ML; Huang CI; Yang JF; Lin CI; Hsieh MH; Hsieh MY; Huang CF; Lin WY; Yu ML; Dai CY; Wang HY
    J Clin Lipidol; 2016; 10(2):420-5.e1. PubMed ID: 27055973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.
    Lu S; Kuang M; Yue J; Hu C; Sheng G; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):95. PubMed ID: 36207744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study.
    Liu L; Wang C; Hu Z; Deng S; Yang S; Zhu X; Deng Y; Wang Y
    Environ Health Prev Med; 2024; 29():5. PubMed ID: 38325840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease.
    Turecký L; Kupčová V; Urfinová M; Repiský M; Uhlíková E
    Vnitr Lek; 2021; 67(E-2):4-8. PubMed ID: 34074098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease.
    Wang Y; Song W; Yuan Q; Mai M; Luo M; Fan J; Zhang P; Guo H
    Scand J Gastroenterol; 2024 Apr; 59(4):469-479. PubMed ID: 38131633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
    J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis.
    Xie Y; Huang K; Zhang X; Wu Z; Wu Y; Chu J; Kong W; Qian G
    Front Med (Lausanne); 2023; 10():1164096. PubMed ID: 37256087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017-2020.
    Lu CF; Cang XM; Liu WS; Wang LH; Huang HY; Sang SM; Wang XQ; Fang XX; Xu F
    Lipids Health Dis; 2023 Aug; 22(1):130. PubMed ID: 37568178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.
    Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S
    Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.